Establishment Labs Holdings (ESTA) Shares Outstanding (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Shares Outstanding (Entity) of $29.8 million for Q1 2026, up 1.63% year-over-year from $29.3 million in Q1 2025, and little changed quarter-over-quarter from $29.7 million in Q4 2025.
Establishment Labs Holdings (ESTA) Shares Outstanding (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $29.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.63% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $29.8 million (up 1.63% YoY), while the FY2025 annual figure was $29.7 million, up 1.77% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $29.8 million, roughly flat from $29.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $29.8 million in Q1 2026, with the low at $24.6 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $27.9 million (2024), against an average of $27.3 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) increased 1.09% in 2023, then advanced 12.12% in 2024.
- Establishment Labs Holdings' Shares Outstanding (Entity) stood at $24.8 million in 2022, then grew by 6.77% to $26.5 million in 2023, then gained by 10.19% to $29.2 million in 2024, then advanced by 1.77% to $29.7 million in 2025, then advanced by 0.27% to $29.8 million in 2026.
- Business Quant data shows ESTA's Shares Outstanding (Entity) at $29.8 million in Q1 2026, $29.7 million in Q4 2025, and $29.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 30.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.12 Mn |
| Mar 31, 2026 | 29.95 Mn |
| Dec 31, 2025 | 29.62 Mn |
| Sep 30, 2025 | 29.62 Mn |
| Jun 30, 2025 | 28.91 Mn |
| Mar 31, 2025 | 29.48 Mn |
| Dec 31, 2024 | 28.16 Mn |
| Sep 30, 2024 | 28.25 Mn |
| Jun 30, 2024 | 27.91 Mn |
| Mar 31, 2024 | 27.79 Mn |
| Dec 31, 2023 | 25.60 Mn |
| Sep 30, 2023 | 26.03 Mn |
| Jun 30, 2023 | 25.62 Mn |
| Mar 31, 2023 | 24.68 Mn |
| Dec 31, 2022 | 24.46 Mn |
| Sep 30, 2022 | 24.51 Mn |
| Jun 30, 2022 | 24.40 Mn |
| Mar 31, 2022 | 24.31 Mn |
| Dec 31, 2021 | 23.97 Mn |
| Sep 30, 2021 | 24.09 Mn |